NEWTON, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback